MS-CSI: Common and Specific Information From Neuroimaging and Smartphone

Sponsor
Nantes University Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05482906
Collaborator
Rennes University Hospital (Other)
100
1
26
3.8

Study Details

Study Description

Brief Summary

Gait alteration is frequent in MS and limitation in walking ability is a major concern in MS patients. Umanit and LMJL (Nantes university) has developed a device call egait to assess walking ability in individuals (eg MS patients).

Condition or Disease Intervention/Treatment Phase
  • Other: eGait

Detailed Description

This device consists in a commercialized IMU sensor (MetaMotionR Sensor, Mbientilab) worn at the right hip, a smartphone app and dedicated algorithm/mathematical model to extract raw sensor data and calculate individual gait pattern (IGP). This IGP consists of a curve, based on quaternion and representing the rotation recorded by the IMU during an average gait cycle. Pursue previous works conducted on (IGP to assess) gait alteration in MS by adding (to IGP) new information from MRI.

Study Design

Study Type:
Observational
Anticipated Enrollment :
100 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
Individual Gait Pattern and MRI Lesion Load to Quantify Gait Impairment in MS: A Cross Sectional Study.
Anticipated Study Start Date :
Sep 1, 2022
Anticipated Primary Completion Date :
Nov 1, 2024
Anticipated Study Completion Date :
Nov 1, 2024

Outcome Measures

Primary Outcome Measures

  1. Clustering analyze based on IGP [At the inclusion]

    IGP consists of a curve, based on quaternion and representing the rotation recorded by the IMU during an average gait cycle (0-1).

  2. Clustering analyze based on EDSS score [At the inclusion]

    EDSS is an ordinal scale measuring disability and ranging from 0 (normal examination) to 10 (death due to MS) in a 0,5-point increments from score 1.

  3. Clustering analyze based on MRI lesion load [At the inclusion]

    MRI characteristics are spinal and extraspinal lesion volumes.

Secondary Outcome Measures

  1. Correlation with disability [At the inclusion]

    Correlation of IGP obtained during a walk of 25 feet with Expanded Disability Status Scale (EDSS). EDSS is an ordinal scale measuring disability and ranging from 0 (normal examination) to 10 (death due to MS) in a 0,5-point increments from score 1. Here EDSS of 0 to 2 inclusive defined as mild, 2,5 to 4 inclusive as moderate and EFDSS of 4,5 to 6 inclusive defined as severe

  2. Correlation with MRI lesion load [At the inclusion]

    Add lesion load (Spinal and extraspinal lesion volume) from MRI to previous correlation.

  3. Building a predictive model for lesion load involving in walk ability from IGP [At the inclusion]

    Root mean square error between observed and lesion load predicted by the model, calculated by cross-validation.

  4. Building a predictive model for group belonging from group established in main outcome based on IGP [At the inclusion]

    Multiclass accuracy between real and predict group, calculated by cross-validation

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Inclusion Criteria :
  • Diagnosis of MS based on McDonald criteria (including Relapsing-remitting and progressive MS)

  • Over 18 years old /age greater than 18 years

  • Patients followed at Nantes university hospital or Rennes university hospital

  • Last known EDSS before inclusion ranging from 0 to 6 inclusive/EDSS of 0 to 6 inclusive, prior inclusion

  • No relapse within 3 months

  • With a Medullar MRI planed as part as usual care

  • Affiliated person or beneficiary of a social security scheme

Exclusion Criteria :
  • Bilateral aid needed to walk

  • Women who are pregnant

  • Patient having expressed their opposition

  • Patient under guardianship or security measure

Contacts and Locations

Locations

Site City State Country Postal Code
1 Nantes University Hospital Nantes Loire-Atlantique France 44093

Sponsors and Collaborators

  • Nantes University Hospital
  • Rennes University Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Nantes University Hospital
ClinicalTrials.gov Identifier:
NCT05482906
Other Study ID Numbers:
  • RC20_0203
First Posted:
Aug 1, 2022
Last Update Posted:
Aug 1, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Nantes University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 1, 2022